Академический Документы
Профессиональный Документы
Культура Документы
Authors
Brian King, Arsalan P. Rizwan, ...,
Gerald W. Zamponi, Ray W. Turner
Correspondence
rwturner@ucalgary.ca
In Brief
The molecular identity of a Ca2+dependent slow afterhyperpolarization
(sAHP) that controls cortical neuronal
excitability has gone unsolved for over 30
years. King et al. now show that IKCa
(KCa3.1) channels underlie the sAHP in
CA1 pyramidal cells to suppress temporal
summation of EPSPs and mediate spike
accommodation.
Highlights
d
Cell Reports
Report
IKCa Channels Are a Critical Determinant
of the Slow AHP in CA1 Pyramidal Neurons
Brian King,1,2 Arsalan P. Rizwan,1,2 Hadhimulya Asmara,1 Norman C. Heath,1 Jordan D.T. Engbers,1 Steven Dykstra,1
Theodore M. Bartoletti,1 Shahid Hameed,1 Gerald W. Zamponi,1 and Ray W. Turner1,*
1Hotchkiss
SUMMARY
electroencephalography, aging, and several disease states (Disterhoft et al., 2004; Haug and Storm, 2000; Madison and Nicoll,
1986; Martn et al., 2001; Zhang et al., 2013).
Despite the wealth of information on sAHP properties, the molecular identity of the Ca2+-dependent K+ channel(s) underlying
the sAHP has defied explanation. A third possible Ca2+-dependent channel is the intermediate-conductance Ca2+-gated K+
channel (SK4, IKCa, KCa3.1) (Ishii et al., 1997; Joiner et al.,
1997; Logsdon et al., 1997). While these were not originally
thought to be expressed in CNS neurons (reviewed in Wulff
et al., 2007), recent work in cerebellar Purkinje cells and on
IKCa protein distribution suggests a wide potential expression
pattern in central neurons (Engbers et al., 2012; Turner et al.,
2015). The current study tested the hypothesis that IKCa channels contribute to the Ca2+-dependent component of the sAHP
in CA1 pyramidal cells. We report that K+ channels of intermediate conductance with the unique pharmacological profile of IKCa
channels indeed underlie the sAHP, identifying the molecular basis for one of the largest inhibitory responses in central neurons.
RESULTS
The sAHP of CA1 Pyramidal Cells
The sAHP in CA1 hippocampal pyramidal cells is known to
mediate spike accommodation, in which spike frequency is progressively reduced during an injected current pulse and followed
by a post-stimulus afterhyperpolarization (Madison and Nicoll,
1986). The sAHP can also be evoked by synaptic inputs in stratum radiatum (SR) using short stimulus bursts (530 pulses,
50 Hz), with the sAHP apparent during and immediately after
the stimulus train (Figures 1 and 2). To test the functional role
of IKCa channels, we first blocked SK channels using 100 nM
apamin and Kv7 channels with 10 mM XE-991, given a role for
Kv7 channels in other hippocampal neurons (Tzingounis et al.,
2010). It is known that IKCa channels are apamin insensitive
(Wulff et al., 2007), and we confirmed that 10 mM XE-991 had
no effect on IKCa channels (Figure S1A) and did not impede
SR-evoked synaptic transmission (Vervaeke et al., 2006). Any
contribution from the Na-K pump was minimized by recording
at 32 C (Gulledge et al., 2013). To focus on excitatory synaptic
potentials, we applied 50 mM picrotoxin to block GABAergic
transmission. The combination of apamin, XE-991, and picrotoxin produced little qualitative change in the firing response to
Cell Reports 11, 175182, April 14, 2015 2015 The Authors 175
10
mV
10
mV
50 ms
200 ms
SR Stimulation, 30 pulses, 50 Hz
last sec
(7)
500 1000
500 ms
* *
4
2
0
500 1000
1st 200 ms
Fold Frequency
*
8
6
4
2
0
Fold Number
Fold Frequency
1st 500 ms
20
mV
10
mV
last 400 ms
*
(7)
1
0
200 400
Fold Number
TRAM-34
100 ms
6
4
2
0
200 400
5
mV
200 ms
SR Stimulation, 30 pulses, 50 Hz
current pulse injection or SR stimulus trains (see the Supplemental Experimental Procedures and Figures S2A and S2B).
The role of IKCa channels can be distinguished using the selective blockers TRAM-34, Senicapoc, or NS-6180 (Stocker
et al., 2003; Strbk et al., 2013; Wulff et al., 2001). The selectivity of TRAM-34 has been thoroughly established, with IKCa
channels exhibiting far greater sensitivity to 1 mM TRAM-34
than SK or BK channels (Wulff et al., 2000). Control tests
confirmed that 1 mM TRAM-34 had no significant effect on BK,
Kv7.3, or TMEM16B channels expressed in tsA-201 cells or
the SR-evoked excitatory postsynaptic current paired-pulse ratio in tissue slices (Figures S1BS1E). Since TRAM-34 must first
be internalized to block IKCa channels, we found that the fastest
and most reliable block was obtained through internal perfusion
of 1 mM TRAM-34 through the electrode (see the Experimental
Procedures).
IKCa Channels Contribute to Spike Accommodation and
Temporal Summation
Internal perfusion of 1 mM TRAM-34 reduced spike accommodation and the sAHP in rat CA1 pyramidal cells evoked by current
injection or a 30-pulse SR stimulus train (Figures 1A and 1B).
The initial suppression of excitatory postsynaptic potential
(EPSP) summation by the sAHP during a 50-Hz SR stimulus train
176 Cell Reports 11, 175182, April 14, 2015 2015 The Authors
5
mV
KCa3.1-/-
ns
TRAM-34
20
mV
6
4
2
0
TRAM-34
10
mV
1 sec
KCa3.1-/-
(4)
Cont TRAM
12
ns
10
8
6
4
2
(7)
(7)
Cont
TRAM
(6)
(5)
Cont TRAM
1.5
1.4
1.3
1.2
1.1
1.0
0
50 Hz, 30 SR stimuli
10
15
20
25
30
Stimulus Number
Wild-type
Senicapoc
wild type
10
0
Control
TRAM-34
15
14
-65
mV
20
Wild-type
-66
mV
(4)
25
Cont TRAM
500 ms
ns
Spike number
Control
Frequency (Hz)
F
Control
KCa3.1-/-
Control
Control
2
mV
2
mV
1 sec
Control
DC-EBIO
SKA-31
1 sec
DC-EBIO
DC-EBIO+ SKA-31
mice exhibited a characteristic initial high-frequency burst attributable to the actions of BK channels (Gu et al., 2007) but no
prominent spike accommodation (Figure 2A). Infusion of 1 mM
TRAM-34 through the electrode had no significant effect on
the frequency or number of spikes evoked (Figure 2A). Trains
of SR synaptic input in WT mice (30 pulses, 50 Hz) were followed
Control
TRAM-34 (n = 7)
30
Subtraction
Control
ChTx (n = 7)
mV
-80 -60 -40 -20
50
pA
100 ms
20 40 60
D
50
20
pA
100 ms
60 mV
-110 mV
mV
20 40 60
30
20
Subtraction
20
10
Control
PKAcat (n = 5)
40
30
Subtraction
20
pA
40
10
pA
50
pA
100 ms
80
60
20
Subtraction
Control
MTx (n = 5)
pA
pA
50
pA
100 ms
mV
60 mV
20 40 60
-110 mV
10
mV
-80 -60 -40 -20-5
20 40 60
[K]o = 3.25 mM
A
mV
[K]o = 140 mM
Control
O3
O2
O1
C
+30
mV
Control
-60
DC-EBIO
+30
Current (pA)
+20
Current (pA)
Control
mV
+30
+120
0
-20
-40
C
O1
O2
-60
30 mV
-40
-60 mV
TRAM-34
-60
BAPTA-AM
Subtraction
+120
50
pA
80 mV
30 mV
1 sec
RMP
-60 mV
TRAM-34
+30
2
pA
200 msec
80 mV
30 mV
RMP
-40
80 mV
-65 mV
Current (pA)
1.0
= 30 pS
0.5
RMP
-0.5
-1.0
-1.5
(-65)
-60
-40
-20
RMP
20
6
4
2
0
-2
ECl
D
mV
+30
-40 mV
-60 mV
1.5
Current (pA)
5
pA
2 sec
120 mV
EK
-60
+30
-4
-6
-8
Control
8-bromo-cAMP
-60
n=6
Predicted transmembrane
potential (mV)
80 mV
5
pA
30 mV
1 sec
RMP
-60 mV
Control
TRAM-34
2
pA
200 msec
o
c
+60 mV
SR stimulation, 5 pulses, 50 Hz
o
c
SR stimulation
100 msec
B
Control
2
pA
Control
TRAM-34
SR
-65 mV
TRAM-34
1 sec
20
pA
Control
60 mV
TRAM-34
1 sec
10
pA
-65 mV
5
pA
1 sec
Control
ChTx
1 sec
4
pA
SR
-65 mV
Control
5
pA
n=9
60 mV
SR stimulation, 5 pulses, 50 Hz
10
pA
ChTx
1 sec
-65 mV
1 sec
TRAM-34, with a small remaining TRAM-34-insensitive component subsequently blocked by 20 mM ouabain (Figures S4D
and S4E).
Interestingly, Ca2+-dependent single channels of 19 pS
conductance were earlier reported in both tissue slices (Lima
and Marrion, 2007) and cultured neurons (Lancaster et al.,
1991). However, in neither case was the molecular identity of
these channels attained. The sAHP in cultured hippocampal
neurons was further reduced by clotrimazole (Shah et al.,
2001), a drug related to TRAM-34 but later recognized as
non-specific. The sAHP and spike accommodation was also
reported to be insensitive to ChTx (Lancaster and Nicoll,
1987; Shah and Haylett, 2000). By comparison, we found
ChTx-sensitive current in outside-out and perforated-patch recordings. The reason for this difference is unknown but might
reflect differences in internal Ca2+ buffering. Indeed, our most
stable recordings of IKCa channels and IsAHP were obtained
using on-cell or perforated-patch recordings that minimize a
disruption of [Ca]i.
IKCa Channels and the sAHP
Our current interpretation for the ionic basis of the sAHP in CA1
pyramidal cells is that the majority of the large-amplitude, Ca2+dependent early phase (45 s) of the sAHP is mediated by IKCa
channels. An additional smaller contribution can be made by Kv7
channels or by the Na-K pump, although the Na-K pump is expected to be most active following intense activation. Delineating IKCa channels as a key contributor to the sAHP in a
cortical pyramidal neuron is significant in that IKCa channels
were believed to be restricted to endothelial cells and activated
microglia in central regions (Wulff et al., 2007). The reasons why
early probes for in situ hybridization did not detect KCa3.1 signal
in brain is unknown, since a signal from at least endothelial
KCa3.1 would be expected. However, recent work has shown
that IKCa channels can be recorded in cerebellar Purkinje cells
(Engbers et al., 2012) and GFP expression driven by the
KCa3.1 promoter suggested an even wider expression pattern
of IKCa (Turner et al., 2015). Indeed, numerous central neurons
express an sAHP that shares many properties with the sAHP in
CA1 pyramidal cells, including Ca2+ dependence, insensitivity
to BK or SK channel blockers, and rapid block by kinase pathways, with a very close parallel found in enteric and myenteric
neurons (Neylon et al., 2004; Vogalis et al., 2002). The finding
that IKCa-mediated suppression of temporal summation is still
active under conditions of intact GABAergic inhibition further ensures that the influence of IKCa channels will be present under
physiological conditions. We thus expect the role for IKCa channels in generating an sAHP to be widely applicable to other classes of central neurons.
EXPERIMENTAL PROCEDURES
Animal Care and Slice Preparation
Experiments were conducted on P18P24 male Sprague-Dawley rats (Charles
River) raised from timed-pregnant dams or on breeding colonies of P25P50
C57BL/6 WT mice or P25P60 KCa3.1/ mice (UC Davis) (as described
in Turner et al., 2015) according to approved procedures by the Canadian
Council of Animal Care. Details on in vitro slice preparation are provided in
the Supplemental Experimental Procedures.
Electrophysiology
A suite of patch-clamp recording techniques was used to record from rat or
mouse hippocampal CA1 pyramidal cells under current- or voltage-clamp
conditions in the in vitro slice preparation (3234 C) and from tsA-201 cells
(22 C). Details on recording equipment and patch recording configurations
can be found in the Supplemental Experimental Procedures.
Solutions and Drug Applications
The lipophilic drugs TRAM-34, Senicapoc, and NS-6180 must be internalized
to target an internal binding site (Stocker et al., 2003; Strbk et al., 2013;
Wulff et al., 2001). Using bath perfusion of these drugs, channel activity was
reduced in on-cell recordings in 1015 min while whole-cell recordings could
take 2030 min to achieve full block. The most reliable block was obtained with
TRAM-34 and Senicapoc, with infusion of 1 mM TRAM-34 by exchanging the
electrode solution (ALA Scientific Instruments) achieving a block of IKCa channels in <10 min. The majority of tests in whole-cell recording configuration thus
used internal perfusion of 1 mM TRAM-34. Further details on electrode and
external solutions are given in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.03.026.
AUTHOR CONTRIBUTIONS
R.W.T., B.K., A.P.R., H.A., N.C.H., and G.W.Z. designed the study or provided
reagents. B.K., A.P.R., H.A., N.C.H., S.H., J.D.T.E., and T.M.B. performed the
experiments or analyzed the data. R.W.T., B.K., and A.P.R. wrote the
manuscript.
ACKNOWLEDGMENTS
We gratefully acknowledge a gift of Senicapoc from H. Wulff (University of California, Davis) and thank H. Wulff and J. Adelman (Vollum Institute, OR) for
helpful comments on the manuscript. M. Kruskic and L. Chen provided expert
technical assistance. This work was supported by the Canadian Institutes of
Health Research (CIHR; R.W.T. and G.W.Z.), studentships from the Alberta
Heritage Foundation for Medical Research (AHFMR; J.D.T.E), a T. Chen
Fong award (J.D.T.E.), the Killam Foundation (J.D.T.E.), a CIHR-CGS PhD studentship (J.D.T.E.), and CIHR and Alberta Innovates-Health Solutions (AI-HS)
postdoctoral fellowships (T.M.B.). G.W.Z. and R.W.T. are AI-HS Scientists.
Received: November 27, 2014
Revised: January 30, 2015
Accepted: March 10, 2015
Published: April 9, 2015
REFERENCES
Adelman, J.P., Maylie, J., and Sah, P. (2012). Small-conductance Ca2+-activated K+ channels: form and function. Annu. Rev. Physiol. 74, 245269.
Andrade, R., Foehring, R.C., and Tzingounis, A.V. (2012). The calciumactivated slow AHP: cutting through the Gordian knot. Front. Cell. Neurosci.
6, 47.
Berkefeld, H., Fakler, B., and Schulte, U. (2010). Ca2+-activated K+ channels:
from protein complexes to function. Physiol. Rev. 90, 14371459.
Bond, C.T., Herson, P.S., Strassmaier, T., Hammond, R., Stackman, R.,
Maylie, J., and Adelman, J.P. (2004). Small conductance Ca2+-activated K+
channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents. J. Neurosci. 24, 53015306.
Castle, N.A., London, D.O., Creech, C., Fajloun, Z., Stocker, J.W., and Sabatier, J.M. (2003). Maurotoxin: a potent inhibitor of intermediate conductance
Ca2+-activated potassium channels. Mol. Pharmacol. 63, 409418.
Cell Reports 11, 175182, April 14, 2015 2015 The Authors 181
Disterhoft, J.F., Wu, W.W., and Ohno, M. (2004). Biophysical alterations of hippocampal pyramidal neurons in learning, ageing and Alzheimers disease.
Ageing Res. Rev. 3, 383406.
Sah, P., and Isaacson, J.S. (1995). Channels underlying the slow afterhyperpolarization in hippocampal pyramidal neurons: neurotransmitters modulate the
open probability. Neuron 15, 435441.
Engbers, J.D.T., Anderson, D., Asmara, H., Rehak, R., Mehaffey, W.H.,
Hameed, S., McKay, B.E., Kruskic, M., Zamponi, G.W., and Turner, R.W.
(2012). Intermediate conductance calcium-activated potassium channels
modulate summation of parallel fiber input in cerebellar Purkinje cells. Proc.
Natl. Acad. Sci. USA 109, 26012606.
Shah, M., and Haylett, D.G. (2000). Ca(2+) channels involved in the generation
of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurons. J. Neurophysiol. 83, 25542561.
Fioretti, B., Castigli, E., Calzuola, I., Harper, A.A., Franciolini, F., and Catacuzzeno, L. (2004). NPPB block of the intermediate-conductance Ca2+-activated
K+ channel. Eur. J. Pharmacol. 497, 16.
Gu, N., Vervaeke, K., and Storm, J.F. (2007). BK potassium channels facilitate
high-frequency firing and cause early spike frequency adaptation in rat CA1
hippocampal pyramidal cells. J. Physiol. 580, 859882.
Gulledge, A.T., Dasari, S., Onoue, K., Stephens, E.K., Hasse, J.M., and Avesar,
D. (2013). A sodium-pump-mediated afterhyperpolarization in pyramidal neurons. J. Neurosci. 33, 1302513041.
Haug, T., and Storm, J.F. (2000). Protein kinase A mediates the modulation of
the slow Ca(2+)-dependent K(+) current, I(sAHP), by the neuropeptides CRF,
VIP, and CGRP in hippocampal pyramidal neurons. J. Neurophysiol. 83,
20712079.
Huang, W.C., Xiao, S., Huang, F., Harfe, B.D., Jan, Y.N., and Jan, L.Y. (2012).
Calcium-activated chloride channels (CaCCs) regulate action potential and
synaptic response in hippocampal neurons. Neuron 74, 179192.
Ishii, T.M., Silvia, C., Hirschberg, B., Bond, C.T., Adelman, J.P., and Maylie, J.
(1997). A human intermediate conductance calcium-activated potassium
channel. Proc. Natl. Acad. Sci. USA 94, 1165111656.
Joiner, W.J., Wang, L.Y., Tang, M.D., and Kaczmarek, L.K. (1997). hSK4, a
member of a novel subfamily of calcium-activated potassium channels.
Proc. Natl. Acad. Sci. USA 94, 1101311018.
Lancaster, B., and Nicoll, R.A. (1987). Properties of two calcium-activated
hyperpolarizations in rat hippocampal neurones. J. Physiol. 389, 187203.
Lancaster, B., Nicoll, R.A., and Perkel, D.J. (1991). Calcium activates two types
of potassium channels in rat hippocampal neurons in culture. J. Neurosci. 11,
2330.
Lima, P.A., and Marrion, N.V. (2007). Mechanisms underlying activation of the
slow AHP in rat hippocampal neurons. Brain Res. 1150, 7482.
Logsdon, N.J., Kang, J., Togo, J.A., Christian, E.P., and Aiyar, J. (1997).
A novel gene, hKCa4, encodes the calcium-activated potassium channel in
human T lymphocytes. J. Biol. Chem. 272, 3272332726.
Madison, D.V., and Nicoll, R.A. (1984). Control of the repetitive discharge of rat
CA 1 pyramidal neurones in vitro. J. Physiol. 354, 319331.
Madison, D.V., and Nicoll, R.A. (1986). Cyclic adenosine 30 ,50 -monophosphate
mediates beta-receptor actions of noradrenaline in rat hippocampal pyramidal
cells. J. Physiol. 372, 245259.
Martn, E.D., Araque, A., and Buno, W. (2001). Synaptic regulation of the slow
Ca2+-activated K+ current in hippocampal CA1 pyramidal neurons: implication in epileptogenesis. J. Neurophysiol. 86, 28782886.
Neylon, C.B., Nurgali, K., Hunne, B., Robbins, H.L., Moore, S., Chen, M.X., and
Furness, J.B. (2004). Intermediate-conductance calcium-activated potassium
channels in enteric neurones of the mouse: pharmacological, molecular and
immunochemical evidence for their role in mediating the slow afterhyperpolarization. J. Neurochem. 90, 14141422.
Pedarzani, P., Krause, M., Haug, T., Storm, J.F., and Stuhmer, W. (1998). Modulation of the Ca2+-activated K+ current sIAHP by a phosphatase-kinase balance under basal conditions in rat CA1 pyramidal neurons. J. Neurophysiol.
79, 32523256.
182 Cell Reports 11, 175182, April 14, 2015 2015 The Authors
Cell Reports
Supplemental Information
Figure S2, related to Figures 1 and 2. Background channel blockers have minimal effects on the
sAHP and IsAHP
(A) Perfusion of 100 nM apamin, 10 M XE-991, and 50 M picrotoxin to block SK and Kv7 channels
and GABAergic transmission slightly reduce but do not eliminate spike accommodation during current
pulse injection.
(B) The early phase of the sAHP following a train of SR input is blocked (arrow) and the sAHP is more
evident after perfusion of apamin, XE-991, and picrotoxin (inset).
(C) The sAHP evoked by a train of SR stimuli is progressively reduced by block of NMDA receptors (DLAP5, 25 M) and AMPA receptors (DNQX, 10 M).
(D, E) Recordings of IsAHP evoked as a tail current under whole-cell voltage clamp using a depolarizing
step command (D) or following a SR stimulus train (E). Perfusion of apamin, XE-991, and picrotoxin
selectively reduces the early component of outward current consistent with a block of SK channels. Spikes
and stimulus artefacts in (B, C, E) and currents during the command pulse in (D) are truncated.
Figure S3, related to Figures 1 and 2. The sAHP in whole-cell or perforated patch configurations
resists wash out
(A) Whole-cell current clamp (left) and perforated patch voltage clamp (right) recordings from P18-22 rat
CA1 pyramidal cells. Applying a stimulus protocol consisting of either 5 suprathreshold SR stimuli (50 Hz)
(left) or a 500 ms step to 60 mV to evoke IsAHP (right) revealed sAHP currents that were stable for over
30 min. Recordings were started after 5 min stabilization time post-breakin or perforation, and shown here
comparing initial recordings (0 min, black) and after 30 min (red).
(B) Summary plots of mean sAHP or IsAHP areas and peak magnitudes after the end of the stimulus (n = 7
for both conditions).
Values are mean SEM.
Figure S4, related to the Discussion. The majority of the sAHP is calcium-dependent and TRAM-34sensitive
(A, B) Representative whole-cell recordings of IsAHP evoked by a step command to +60 mV at 34C is
blocked by perfusion of low extracellular calcium (a), as is an inward tail current recorded in another cell
in the presence of internal 1 M TRAM-34 (B).
(C) A perforated patch whole-cell recording at the soma records an IsAHP of 6 sec duration following a
step command to +60 mV at 22 C. The IsAHP is amplified upon generation of a calcium current during
the step command, visible as an all-or-none unclamped calcium spike (inset). Recordings in (B) were
conducted using a KMeSO4-based internal solution with 0.1 EGTA, ATP, GTP, creatine, and 1 M
TRAM-34.
4
(D, E) Representative whole-cell recording from a rat CA1 pyramidal cell applying a stimulus protocol
consisting of 1 nA, 2 ms current pulses delivered at 50 Hz for 3 sec to test the role for the Na-K pump in
generating the sAHP at 35C (as in Gulledge et al. 2013). Internal infusion of TRAM-34 (1 M) blocks a
large component of the sAHP. Subsequent addition of bath perfused 20 M ouabain blocked the small
remaining TRAM-insensitive component of the sAHP. All recordings in (D, E) were conducted in the
presence of 100 nM apamin, 10 M XE-991, and 50 M picrotoxin.
(E) Bar plot of mean sAHP area following the end of the current pulse train for records such as shown in
(D).
Values are mean SEM. *, p < 0.05. Sample numbers for mean values are shown in brackets.
Table S1, related to Figures 3, 4 and 5. Values of Kd/IC50/EC50 and the actual applied concentrations of
agonists and antagonists used.
Inhibitors
Tetrodotoxin
Apamin
TEA
4-AP
CsCl
TRAM-34
Senicapoc
ChTx
Maurotoxin
Ni2+
Cd2+
8-bromo-cAMP
PKACat
XE-991
Activators
DC-EBIO
SKA-31
Actions
Nav1.1-1.4,
1.6-1.7
SK1-3
BK
Kv1.1
Kv1.6
Kv3.x
Kv1.x
Kv2.x
Kv3.x
Kv4.2
HCN1-4
KCa3.1
KCa3.1
KCa3.1
Kv1.2
Kv1.3
Kv1.6
KCa3.1
Kv1.2
Cav3.x
Cav1.x
Cav2.3
PKA-I andII
Kd
20-25 nM
IC50/EC50
Applied
External
1-24 nM
1 M
2-12 nM
80-330 M
0.5 mM
1.7-7 mM
0.09-0.3 mM
0.1-1.5 mM
0.5-4.5 mM
0.02-1.2mM
2-5 mM
0.16-0.20 mM
20 nM
100 nM
5 mM
11 nM
10 nM
1.7-17 nM
0.5-2.6 nM
1 nM
1 nM
0.1 nM
50-300 M
100 nM
100 nM
2.14 M
5 mM
2 mM
2 mM
1 M
1 M
100 nM
300 M
30 M
100 M
0.0150.019 nM
References
(Catterall et al., 2005a;
Zimmer, 2010)
(Sah and Faber, 2002)
See (Coetzee et al., 1999)
for pharmacology of TEA
0.8 M
100 U/ml
KCa3.1
CaMbinding
domain
Kv7.x
2.2 M
10 M
KCa3.1
1 M
260 nM
0.1 M
1 M
Applied
Internal
Animals were anaesthetized by isoflurane inhalation and 270 m dorsal hippocampal slices cut in ice-cold
solution (mM): 215 sucrose, 25 NaHCO3, 20 D-glucose, 2.5 KCl, 0.5 CaCl2, 1.25 NaH2PO4 and 3 MgCl2
bubbled with carbogen gas. The slices were incubated for 10-15 min (34C) in artificial cerebrospinal fluid
(aCSF) composed of (mM): 125 NaCl, 3.25 KCl, 1.5 CaCl2, 1.5 MgCl2, 25 NaHCO3, and 25 D-glucose
bubbled with carbogen gas. Slices were stored at room temperature until recordings conducted at 32-34 C
as a submerged preparation.
Evoking the sAHP
As earlier reported (Wu et al., 2004), the amplitude of the evoked sAHP could differ between cells, with
up to 20% exhibiting little or no detectable sAHP. The current study focused on those cells exhibiting a
detectable sAHP. The combination of apamin, XE-991, and picrotoxin slightly reduced but did not block
spike accommodation evoked during current pulse injection (Figure S2A; n = 8). There was also little
qualitative change in the firing response to SR stimulus trains, although the early phase of the subsequent
AHP (SK-mediated) was reduced and the sAHP was slightly more prominent, likely due to an increase in
calcium influx in the absence of SK channels (Figure S2B; n = 8). The ability to detect both AMPA- and
NMDA-mediated components of the SR-evoked sAHP was also maintained in the presence of apamin, XE991, and picrotoxin (Figure S2C; n = 8). Recording the IsAHP following a step command or a burst of SR
stimuli established that these compounds reduced primarily an early component of outward current
consistent with an SK-mediated response (Figures S2D and S2E; n = 8). Recordings of IsAHP using
whole-cell or perforated patch configurations were stable over 30 min time (Figure S3, n = 7), revealing
minimal influence of washout or a change in access resistance that could account for the actions of applied
drugs.
Patch recordings
Patch recordings were made using Multiclamp 700B amplifiers and Digidata 1440A with DC-10 kHz
bandpass filter and pClamp software. Pipettes were constructed from 1.5 mm O.D. fiber-filled glass (A-M
Systems) with resistance of 4-8 M. Series resistance was compensated with bridge balance circuitry for
current clamp recordings and during voltage clamp recordings by up to 80% compensation. Negative bias
current of < 200 pA was applied during current clamp recordings to maintain a subthreshold resting
potential at ~-65 mV. For whole-cell experiments, control recordings were made >5 min after break in to
promote full stabilization with the internal solution. During whole-cell recording, cells were rejected for
any drift in access resistance of > 20%. On-cell recordings were obtained with a 10 kHz cutoff filter and
processed offline by filtering at 240-500 Hz (Bessel 8-pole).
Solutions and drug applications
Chemicals were obtained from Sigma unless noted. The following drugs were used to block the identified
ion channels to isolate IKCa: BK (TEA, 5 mM; IbTx, 100 nM), SK (apamin, 100 nM), Kv7 (XE-991, 10
M), Kv4.x (4-AP, 5 mM external, 2 mM internal), Kv1.x (TEA, 5 mM; ChTx, 100 nM; MTx, 100 nM),
sodium (TTX, 200 nM - 1 M), HVA calcium (CdCl2, 30 M), LVA calcium (NiCl2, 300 M), HCN
(external CsCl, 2 mM). TRAM-34 (1 M) was applied most often by internal perfusion of the electrode
and by bath perfusion when indicated. Synaptic responses were blocked by: GABA-A (picrotoxin, 50 M),
7
tsA-201 cells were maintained as previously described (Engbers et al., 2012; Rehak et al., 2013) and
transiently transfected with cDNA (5 g/l) of Kv7.3, BK, TMEM16B or IKCa and calmodulin together
with cDNA for GFP to identify cells successfully transfected. Currents were recorded at room temperature
(22 C) in aCSF consisting of (mM): 120 NaCl, 3 NaHCO3, 4.2 KCl, 1.2 KH2PO4, 1.5 MgCl2, 10 DGlucose, 10 HEPES and 1.5 CaCl2 , pH adjusted to 7.3 with NaOH. The following internal solutions were
used for voltage-clamp recordings in tsA-201 cells. For recording IKCa channels, electrodes were filled
8
with (mM): 140 KCl, 5 EGTA, 5 HEPES, 2.83 MgCl2, 4.25 CaCl2 (1.1 M free [Ca]i, Maxchelator
Ca/Mg/ATP/EGTA Calculator, http://maxchelator.stanford.edu/CaMgATPEGTA-TS.htm, 0.165 ionic
strength), pH adjusted to 7.3 with KOH. For recording BK currents, electrodes were filled with (mM): 140
KCl, 5 HEPES, 0.1 EGTA, 0.5 MgCl, 5 ATP, 1 GTP, pH adjusted to 7.3. For recording Kv7.3 currents,
electrodes were filled with (mM): 140 KCl, 0.1 EGTA, 2.5 MgCl2, 10 HEPES, pH adjusted to 7.3. For
recording TMEM16B currents, electrodes were filled with (mM): 15.22 CsCl, 124.78 CsMeSO3, 5 EGTA,
10 HEPES, 1.73 MgCl2, 1.68 CaCl2 (100 nM free [Ca]i, Maxchelator Ca/Mg/ATP/EGTA Calculator,
http://maxchelator.stanford.edu/CaMgATPEGTA-TS.htm), with ECl = -45 mV, and pH adjusted to 7.3.
TMEM16B currents were activated by giving 200 ms voltage steps from a holding potential of -40 mV.
Stimulation
Synaptic input was evoked using a concentric bipolar electrode (Frederick Haer, CBCMX75(JL2))
positioned in the mid SR and driven by a stimulus isolation unit (Digitimer, 0.1-0.2 ms pulse width).
Data Analysis and Statistical Methods
sAHP areas were measured as the area under (in current clamp mode) or over (in voltage clamp mode)
baseline, defined as the mean voltage current or voltage level preceding the current or voltage protocol,
from 200 ms after the protocol to 7 secs after the protocol. Amplitude of the sAHP was measured as the
voltage level 200 ms after the current or stimulus protocol. Mean single channel conductance was
calculated for hyperpolarizing potentials where channel amplitude was best delineated. Data were analyzed
using Clampfit 10 software and custom Matlab R2007B scripts, and statistical analysis in OriginPro 8.
Paired-sample Student t-tests were used unless otherwise indicated.
Supplemental References
Castle, N.A., London, D.O., Creech, C., Fajloun, Z., Stocker, J.W., and Sabatier, J.M. (2003). Maurotoxin: a potent
inhibitor of intermediate conductance Ca2+-activated potassium channels. Mol. Pharmacol. 63, 409-418.
Catterall, W.A., Goldin, A.L., and Waxman, S.G. (2005a). International Union of Pharmacology. XLVII.
Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397-409.
Catterall, W.A., Perez-Reyes, E., Snutch, T.P., and Striessnig, J. (2005b). International Union of Pharmacology.
XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57,
411-425.
Coetzee, W.A., Amarillo, Y., Chiu, J., Chow, A., Lau, D., McCormack, T., Moreno, H., Nadal, M.S., Ozaita, A.,
Pountney, D., et al. (1999). Molecular diversity of K+ channels. Ann. N. Y. Acad. Sci. 868, 233-285.
Engbers, J.D.T., Anderson, D., Asmara, H., Rehak, R., Mehaffey, W.H., Hameed, S., McKay, B.E., Kruskic, M.,
Zamponi, G.W., and Turner, R.W. (2012). Intermediate conductance calcium-activated potassium channels modulate
summation of parallel fiber input in cerebellar Purkinje cells. Proc. Natl. Acad. Sci. U S A 109, 2601-2606.
Hobai, I.A., Bates, J.A., Howarth, F.C., and Levi, A.J. (1997). Inhibition by external Cd2+ of Na/Ca exchange and
L-type Ca channel in rabbit ventricular myocytes. Am. J. Physiol. 272, H2164-2172.
Hoffman, D.A., and Johnston, D. (1998). Downregulation of transient K+ channels in dendrites of hippocampal CA1
pyramidal neurons by activation of PKA and PKC. J. Neurosci. 18, 3521-3528.
Jenkins, D.P., Yu, W., Brown, B.M., Lojkner, L.D., and Wulff, H. (2013). Development of a QPatch Automated
Electrophysiology Assay for Identifying KCa3.1 Inhibitors and Activators. Assay Drug Dev. Technol. 11, 551-560.
Lee, J.H., Gomora, J.C., Cribbs, L.L., and Perez-Reyes, E. (1999). Nickel block of three cloned T-type calcium
channels: low concentrations selectively block alpha1H. Biophys. J. 77, 3034-3042.
Maezawa, I., Jenkins, D.P., Jin, B.E., and Wulff, H. (2012). Microglial KCa3.1 Channels as a Potential Therapeutic
Target for Alzheimer's Disease. Int. J. Alzheimers Dis. 2012, 868972.
Rehak, R., Bartoletti, T.M., Engbers, J.D.T., Berecki, G., Turner, R.W., and Zamponi, G.W. (2013). Low voltage
activation of KCa1.1 current by Cav3-KCa1.1 complexes. PLoS One 8, e61844.
Sah, P., and Faber, E.S. (2002). Channels underlying neuronal calcium-activated potassium currents. Prog.
Neurobiol. 66, 345-353.
Sankaranarayanan, A., Raman, G., Busch, C., Schultz, T., Zimin, P.I., Hoyer, J., Kohler, R., and Wulff, H. (2009).
Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates
the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol. Pharmacol. 75, 281-295.
Schwarz, J.R., Glassmeier, G., Cooper, E.C., Kao, T.C., Nodera, H., Tabuena, D., Kaji, R., and Bostock, H. (2006).
KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier. J. Physiol. 573,
17-34.
Schwede, F., Maronde, E., Genieser, H., and Jastorff, B. (2000). Cyclic nucleotide analogs as biochemical tools and
prospective drugs. Pharmacol. Ther. 87, 199-226.
Stieber, J., Stockl, G., Herrmann, S., Hassfurth, B., and Hofmann, F. (2005). Functional expression of the human
HCN3 channel. J. Biol. Chem. 280, 34635-34643.
Van Renterghem, C., Vigne, P., and Frelin, C. (1995). A charybdotoxin-sensitive, Ca(2+)-activated K+ channel with
inward rectifying properties in brain microvascular endothelial cells: properties and activation by endothelins. J.
Neurochem. 65, 1274-1281.
Wong, R., and Schlichter, L.C. (2014). PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+
signaling, which requires Ser332/334 in the CaM-binding C terminus. J. Neurosci. 34, 13371-13383.
Wu, W.W., Chan, C.S., and Disterhoft, J.F. (2004). Slow afterhyperpolarization governs the development of NMDA
receptor-dependent afterdepolarization in CA1 pyramidal neurons during synaptic stimulation. J. Neurophysiol. 92,
2346-2356.
Wulff, H., and Castle, N.A. (2010). Therapeutic potential of KCa3.1 blockers: recent advances and promising trends.
Expert Rev. Clin. Pharmacol. 3, 385-396.
10
Wulff, H., Gutman, G.A., Cahalan, M.D., and Chandy, K.G. (2001). Delineation of the clotrimazole/TRAM-34
binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J. Biol. Chem. 276,
32040-32045.
Wulff, H., Miller, M.J., Hansel, W., Grissmer, S., Cahalan, M.D., and Chandy, K.G. (2000). Design of a potent and
selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential
immunosuppressant. Proc. Natl. Acad. Sci. U S A 97, 8151-8156.
Zimmer, T. (2010). Effects of tetrodotoxin on the mammalian cardiovascular system. Mar. Drugs 8, 741-762.
11